These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
122 related items for PubMed ID: 37884111
1. Reversed Septal Curvature Is Associated With Nonsustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy. He Y, Zhou J. Am J Cardiol; 2024 Jan 01; 210():195-200. PubMed ID: 37884111 [Abstract] [Full Text] [Related]
2. Non-sustained ventricular tachycardia in hypertrophic cardiomyopathy: an independent marker of sudden death risk in young patients. Monserrat L, Elliott PM, Gimeno JR, Sharma S, Penas-Lado M, McKenna WJ. J Am Coll Cardiol; 2003 Sep 03; 42(5):873-9. PubMed ID: 12957435 [Abstract] [Full Text] [Related]
3. Obstructive sleep apnea is associated with nonsustained ventricular tachycardia in patients with hypertrophic obstructive cardiomyopathy. Wang S, Cui H, Song C, Zhu C, Wu R, Meng L, Yu Q, Huang X, Wang S. Heart Rhythm; 2019 May 03; 16(5):694-701. PubMed ID: 30576881 [Abstract] [Full Text] [Related]
4. Diffuse Ventricular Fibrosis on Cardiac Magnetic Resonance Imaging Associates With Ventricular Tachycardia in Patients With Hypertrophic Cardiomyopathy. McLELLAN AJ, Ellims AH, Prabhu S, Voskoboinik A, Iles LM, Hare JL, Kaye DM, Macciocca I, Mariani JA, Kalman JM, Taylor AJ, Kistler PM. J Cardiovasc Electrophysiol; 2016 May 03; 27(5):571-80. PubMed ID: 26840595 [Abstract] [Full Text] [Related]
9. Prognostic value of non-sustained ventricular tachycardia and the potential role of amiodarone treatment in hypertrophic cardiomyopathy: assessment in an unselected non-referral based patient population. Cecchi F, Olivotto I, Montereggi A, Squillatini G, Dolara A, Maron BJ. Heart; 1998 Apr 03; 79(4):331-6. PubMed ID: 9616338 [Abstract] [Full Text] [Related]
10. Late hyperenhancement in gadolinium-enhanced magnetic resonance imaging: comparison of hypertrophic cardiomyopathy patients with and without nonsustained ventricular tachycardia. Dimitrow PP, Klimeczek P, Vliegenthart R, Pasowicz M, Oudkerk M, Podolec P, Tracz W, Dubiel JS. Int J Cardiovasc Imaging; 2008 Jan 03; 24(1):77-83; discussion 85-7. PubMed ID: 17624806 [Abstract] [Full Text] [Related]
11. Spectrum and prognostic significance of arrhythmias on ambulatory Holter electrocardiogram in hypertrophic cardiomyopathy. Adabag AS, Casey SA, Kuskowski MA, Zenovich AG, Maron BJ. J Am Coll Cardiol; 2005 Mar 01; 45(5):697-704. PubMed ID: 15734613 [Abstract] [Full Text] [Related]
14. Non sustained ventricular tachycardia in hypertrophic cardiomyopathy and new ultrasonic derived parameters. Di Salvo G, Pacileo G, Limongelli G, Baldini L, Rea A, Verrengia M, D'Andrea A, Russo MG, Calabrò R. J Am Soc Echocardiogr; 2010 Jun 01; 23(6):581-90. PubMed ID: 20362415 [Abstract] [Full Text] [Related]
19. Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention. Yazaki K, Suzuki A, Shiga T, Minami Y, Arai K, Ashihara K, Shoda M, Hagiwara N. BMC Cardiovasc Disord; 2021 Feb 19; 21(1):106. PubMed ID: 33607967 [Abstract] [Full Text] [Related]
20. High signal intensity on T2-weighted cardiac magnetic resonance imaging correlates with the ventricular tachyarrhythmia in hypertrophic cardiomyopathy. Hen Y, Iguchi N, Machida H, Takada K, Utanohara Y, Sumiyoshi T. Heart Vessels; 2013 Nov 19; 28(6):742-9. PubMed ID: 23097076 [Abstract] [Full Text] [Related] Page: [Next] [New Search]